ARCHIVES

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

IOM Selects Advisors To Defense Department

February 5, 1993

Adjuvant Radiation Treatment Shows Improved Survival In Elderly, Early-Stage Patients

November 30, 2012

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007